Blogs

Grant Thornton has been a long-term supporter of Sankalp India Foundation, consistently contributing through regular blood drives and CSR initiatives. Their unwavering commitment has helped sustain treatment and care for children living with thalassemia and other blood disorders. 

On 5th December, Grant Thornton organised a blood donation drive in partnership with Sankalp, which was met with enthusiastic participation. A total of 171 units of blood were collected, providing essential support for patients who rely on regular transfusions to survive

2025 was a landmark year for Sankalp India Foundation, a year when compassion became a measurable impact and every new milestone brought India closer to freedom from thalassemia and sickle cell disease. Across its core programs of Prevention, Management, and Cure, Sankalp continued to blend science, service, and empathy to reach more children and families than ever before.

Beginning the Year with Purpose
The year began with renewed energy and clear goals. January saw strong achievements from the year before:

Siva Kumar Naik was devastated when his baby, K. Bavya Bai, was diagnosed with Thalassemia Major. With no knowledge of the condition, his family endured months of confusion, fear, and hospital visits, struggling to find proper care.

Pujitha was a healthy baby until her parents noticed her pale complexion and hardened abdomen. A hospital visit confirmed that she had Thalassemia Major. With little guidance, they struggled to manage her condition, leaving her hemoglobin dangerously low and her ferritin levels soaring to 5000.

Hope arrived in the form of Sankalp India Foundation, our experts were able to guide her treatment. She received Super Transfusion Therapy and double chelation treatment. Today, her ferritin has dropped to 3000, and she’s thriving, with energy levels to rival any other child her age. 

A family ditched the traditional party and instead chose

The Satellite Max Coagulation Analyzer automates PT and APTT testing, processing 20 samples per batch and reducing turnaround time. With full automation replacing our semi-automatic system, manual work is reduced, and efficiency is significantly improved. In-housing testing ensures faster diagnoses and treatments, strengthening our commitment to patient care.

165 women among our 277-member team is no ordinary feat. And that’s why we say, women are the driving force behind our mission at Sankalp India Foundation. They serve as caregivers, doctors, coordinators, and changemakers, ensuring no child suffers due to lack of care.

On 14th March, a small HLA camp was organized at Jalaram Day Care Centre, Ahmedabad, where

A Deccan Herald

By proactively organizing blood donation drives, we stay ahead of shortages.

In March, Sankalp India Foundation organized impactful blood donation drives with incredible support from New Horizon College of Engineering, Epsilon, Trane Technologies, and Sansera Engineering, and many more.    

A special highlight was the pan-India blood donation drive conducted with the Titan Group in honor of their founder, Mr. Xerxes Desai’s birth anniversary on 19th March.

Sankalp India Foundation proudly launched the Sankalp Hemoglobinopathy Academy for Learning (SHeAL), a pioneering initiative dedicated to training professionals in hemoglobinopathy prevention, management, and care.

The first program was a 4-day Orientation for Prevention Centre Coordinators from March 19–22, 2025, at Bhagwan Mahaveer Jain Hospital, Bangalore. It marked the beginning of a series of impactful training sessions under SHeAL, to develop highly skilled, intent-driven professionals.